Cardiovascular Innovations 2019

CARDIOVASCULAR INNOVATIONS 2019 JULY 18-20, 2019 Featuring Complications Pre-Course on July 17HYATT REGENCY DENVER AT COLORADO CONVENTION CENTER Cardiovascular Innovations 2019 is a world-class meeting focused on state-of-the-art therapy for peripheral, coronary, and structural heart disease. The conference features: Highly interactive expert discussions focused on professional experiences An emphasis on the latest innovations in interventional cardiovascular care Live case transmissions by the world's leading operators in the United States and Europe Satellite symposia and hands-on workshops TARGET AUDIENCE Cardiovascular Innovations 2019 is designed to meet the needs of cardiologists, surgeons, internists, trainees, investigators, nurses, nurse practitioners, physician assistants and allied health care staff who participate in the care of patients with coronary, peripheral, and structural cardiovascular diseases. The focus of the conference is on innovative health care solutions for these patients. LEARNING OBJECTIVES Establish the diagnosis and select optimal treatment strategies for patients with both stable and unstable coronary artery disease.  Describe the guideline based indications and best-practice recommendations for the use of hemodynamic support devices, intra-vascular imaging techniques, and physiologic assessment of intravascular hemodynamics, structural heart devices, antiplatelet, lipid-lowering and antithrombotic drug interventions. Recognize different manifestations of patient presentation with carotid disease, acute and chronic DVT, pulmonary embolism, thoracic and abdominal aortic aneurysms, peripheral artery disease (PAD) and identify high-risk subsets that would benefit from revascularization. Outline the risks and benefits of endovascular and surgical revascularization for patients with CLI. List potential complications associated with endovascular treatment of carotid disease, acute and chronic DVT, pulmonary embolism, thoracic and abdominal aortic aneurysms, and CLI. Define success when treating complex PAD. Outline the components of a multidisciplinary team for structural, complex coronary, and CLI. State the goals and identify the appropriate outcomes when treating end stage PAD and CLI patients.  Identify and treat patients with complex coronary artery, peripheral vascular, valve, or arrhythmic heart disease. Define state-of-the-art management pearls to treat patients with hyperlipidemia, heart failure and structural heart disease. AGENDA Please check back soon for the 2019 agenda. To join our mailing list and be notified when the agenda is released, please join our mailing list here. ACCREDITATION Physicians  CMEsolutions has given preliminary approval for 23 AMA credits. The CMEsolutions is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Pharmacists  This activity is eligible for ACPE credit; see final CPE activity announcement for specific details. Nurses This activity has been submitted to the Continuing Nursing Education Group, for approval to award nursing contact hours. The Continuing Nursing Education Group is accredited as an approver of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. For more information regarding contact hours, please call Cardiovascular Innovations Foundation at 440-821-1026. Radiologic Technologists  Category A/A+ CE credit is pending approval by the ASRT. EXHIBITS & SPONSORSHIP OPPORTUNITIES Cardiovascular Innovations Foundation is pleased to offer a variety of sponsorship and exhibit opportunities for CVI2019. Please visit cvinnovations.org to download the sponsorship opportunitites prospectus for more information. ABOUT CARDIOVASCULAR INNOVATIONS FOUNDATION Cardiovascular disease is the number one cause of death globally, accounting for nearly 17.5 million deaths each year. Cardiovascular disease may strike those in their prime years and, due to population aging, also afflict elderly people who are otherwise living healthy lives. Improvements in cardiovascular therapy have markedly reduced procedural risk, and thereby enabled the treatment of a broad range of patients, more than ever before in the history of medicine. Nonetheless, significant disparities in the delivery of cardiovascular care continue to exist, leading to large unmet clinical needs for many patients worldwide. Innovation in the delivery of cardiovascular care, as well as education of the public at-large, is essential for optimizing the management of these patients. The Cardiovascular Innovations Foundation is organized and operated exclusively for charitable, scientific, and educational purposes within the meaning of Section 501(c)(3) of the Internal Revenue Code. The mission of the Foundation is to address unmet needs in cardiovascular care through the study, design, and development of innovative health care solutions and education of health care providers and the larger public. BOARD OF DIRECTORS Subhash Banerjee, MD, FACC, FSCAIProfessor of MedicineUniversity of Texas Southwestern Medical CenterChief, Division of CardiologyDirector, Cardiac Catheterization LaboratoryVA North Texas Health Care SystemEmmanouil S. Brilakis, MD, PhD, FACC, FAHA, FSCAI, FESCDirector, Center for Complex Coronary InterventionsMinneapolis Heart Institute at Abbott Northwestern Hospital Mehdi H. Shishehbor, DO, MPH, PhD, FACC, FAHA, FSCAIProfessor of Medicine, CWRUCo-Chair, Harrington Heart & Vascular InstituteDirector, Cardiovascular Interventional CenterCo-Director, Vascular CenterUniversity Hospitals of ClevelandPaul Sorajja, MD, FACC, FAHA, FSCAIDirector, Center for Valve and Structural Heart DiseaseMinneapolis Heart Institute at Abbott Northwestern HospitalDirector, Valve Science CenterMinneapolis Heart Institute Foundation